
Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease
According to a Town News press release, Sound Pharmaceuticals, a biopharmaceutical company based in Seattle, received FDA approval for their Phase 3 clinical trial on SPI-1005. The trial, STOPMD-3,…